Articles From: - Altera Announces Second Quarter Results; Raises Dividend to - PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism


SAN JOSE, Calif.
Sign-up for - Altera Announces Second Quarter Results; Raises Dividend investment picks
American Midstream Partners, LP (NYSE: AMID) announced today that the board of directors of its general partner declared a quarterly cash distribution of $0.4625 per unit, representing $1.85 per unit on an annualized basis.
Sign-up for - American Midstream Announces Quarterly Distribution investment picks
Digi International® Inc. (NASDAQ:DGII)( www.digi.com ) reported revenue of $47.9 million for the third fiscal quarter of 2014, compared with $48.8 million for the third fiscal quarter of 2013, a decrease of $0.9 million, or 1.9%. Net loss was $0.1 million, or $0.00 per diluted share, in the third fiscal quarter of 2014 compared to net income of $1.5 million, or $0.06 per diluted share, in the year ago comparable quarter.
Sign-up for - Digi International Reports Third Fiscal Quarter 2014 Results investment picks
Weingarten Realty (NYSE: WRI) announced today the results of its operations for the quarter ended June 30, 2014.
Sign-up for - Weingarten Realty’s Transformed Portfolio Produces Same Property NOI Increase of 3.5% investment picks
- Net Sales of $292.3 Million, Up 20.5 Percent from the Third Quarter of 2013 - Non-GAAP Gross Margin of 56.0 Percent - GAAP Gross Margin of 52.5 Percent, Inclusive of Restructuring and Acquisition Related Charges - Operating Cash Flow of $54.4 Million - Book-to-Bill Ratio Greater than 1:1 ALISO VIEJO, Calif.
Sign-up for - Microsemi Reports Fiscal Third Quarter 2014 Results investment picks
Oral Rolapitant New Drug Application (NDA) on Track for Submission to U.S. FDA Enrollment in Niraparib NOVA Trial Non-gBRCA Cohort Expected to Be Complete at Year End Enrollment in Phase 1 Trial of Niraparib in Patients with Ewing's Sarcoma Initiated Anti-TIM-3 Clinical Lead and Back Up Antibodies Identified Cash and Cash Equivalents Totaled Approximately $151 Million as of June 30, 2014 WALTHAM, Mass., July 24, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) , an oncology-focused biopharmaceutical company, today reported financial results for the second quarter of 2014.
Sign-up for - TESARO Announces Second-Quarter 2014 Operating Results investment picks
NETGEAR, Inc. (NASDAQ: NTGR), a global networking company that delivers innovative products to consumers, businesses and service providers, today reported financial results for the second quarter ended June 29, 2014.
Sign-up for - NETGEAR® Reports Second Quarter Results investment picks
Rite Aid Corporation (NYSE: RAD) today announced that Darren Karst, a highly experienced retail finance executive, is joining Rite Aid as executive vice president and chief financial officer, effective Aug.
Sign-up for - Darren Karst Appointed Rite Aid Executive Vice President and Chief Financial Officer investment picks
Lattice Semiconductor Corporation (NASDAQ: LSCC), the leader in low power, small form factor and customizable solutions announced financial results today for the fiscal second quarter ended June 28, 2014.
Sign-up for - Lattice Semiconductor Reports Second Quarter 2014 Results investment picks
NGL Energy Partners LP (NYSE: NGL) announced today that the Board of Directors of its general partner declared a quarterly distribution of $0.58875 per unit ($2.355 on an annualized basis) for the quarter ended June 30, 2014.
Sign-up for - NGL Energy Partners Announces Increased Quarterly Cash Distribution investment picks
HAMILTON, Bermuda, July 24, 2014 (GLOBE NEWSWIRE) -- Maiden Holdings, Ltd.
Sign-up for - Maiden Holdings Announces Dividends on Common Shares and Preference Shares investment picks
NEW YORK (MarketWatch) -- Shares of real estate websites Zillow Inc. (ZILLOW.XX) and Trulia Inc. (TRLA) surged in afternoon trade Thursday, after Bloomberg said Zillow is seeking to buy Trulia, citing people with knowledge of the matter.
Sign-up for - Zillow, Trulia shares surge on report Zillow seeks to buy smaller rival investment picks
2014/7/24
DALLAS, July 24, 2014 /PRNewswire/ -- This summer AT&T * will begin lighting up Dallas, Fort Worth, and surrounding cities with U-verse with AT&T GigaPower.** The AT&T GigaPower network will provide services offered over an all-fiber network featuring symmetrical upload and download broadband speeds of up to 1 gigabit per second, the fastest broadband speeds available in and around the metroplex.*** In the Dallas area, the initial AT&T GigaPower network deployment will launch in Highland Park and University Park with speed capability of up to 1 Gbps.
Sign-up for 2014/7/24 - U-verse® with AT&T GigaPower(SM) to Launch in Dallas, Fort Worth, and Surrounding Cities this Summer investment picks
ATLANTA, July 24, 2014 (GLOBE NEWSWIRE) -- According to the latest Equifax (NYSE:EFX) National Consumer Credit Trends Report, the total balance of auto loans mid-way through 2014 is $902.2 billion, a record high and an increase of more than 10% from same time a year ago.
Sign-up for - Equifax Reports Auto Loan Balances Hit All-Time High Mid-Way Through 2014 investment picks
Supports greater planning and saving; helps investors understand how their account balance translates to retirement income WINDSOR, Conn.
Sign-up for - Voya Financial Launches myOrangeMoney™ Digital Experience for Retirement Plan Customers investment picks
2014/7/24
- Management to Conduct Conference Call on Tuesday, July 29th at 11am ET - BALLERUP, Denmark , July 24, 2014 /PRNewswire/ -- LiqTech International Inc., (NYSE MKT: LIQT), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced that it will conduct a conference call on July 29th at 11am ET to discuss the recent stock offering and LiqTech's announcement that it has reached an agreement to acquire Provital Solutions A/S, a Denmark -based water solutions company specializing in integrated filtration solutions for the swimming pool and spa market segments.
Sign-up for 2014/7/24 - LiqTech International to Discuss Recent Stock Offering and Agreement to Acquire Provital Solutions investment picks
2014/7/24
NEW YORK (MarketWatch) -- Morgan Stanley (MS) has been fined $275 million by the Securities and Exchange Commission for misleading investors in a pair of residential mortgage-backed securities offered in 2007 that the firm underwrote.
Sign-up for 2014/7/24 - SEC fines Morgan Stanley $275 mln over subprime RMBS investment picks
WALTHAM, Mass.
Sign-up for - Care.com Appoints Caroline Sheu Chief Marketing Officer investment picks
Agilysys, Inc. (Nasdaq:AGYS) , a leading provider of innovative information technology and hospitality software and services, announced today that it will release its fiscal 2015 first quarter results before the market opens on Thursday, August 7, 2014 and will host a conference call and webcast at 9:00 a.m. ET on Thursday, August 7.
Sign-up for - Agilysys to Report Fiscal 2015 First Quarter Results on August 7 and Host Conference Call and Webcast investment picks
2014/7/24
Separating sustainable sources from non-sustainable sources in the production of palm oil and palm kernel oil is highly complicated, but Procter & Gamble (NYSE:PG) is stepping up to address the problem.
Sign-up for 2014/7/24 - P&G Launches Work with Small Farmers to Ensure No Deforestation in Its Palm Oil Supply Chain investment picks
2014/7/24
Verizon gives customers more reason to love NFL Mobile.
Sign-up for 2014/7/24 - Football Fans: Want more NFL? You got it! investment picks
Survey Finds That Positive Risk-Adjusted Returns Are More Important Than Overall Returns forNearly Half of Respondents OAKS, Pa.
Sign-up for - SEI Poll: Nonprofits Focus On Risk Management In 2014 investment picks
2014/7/24
ESCONDIDO, Calif.
Sign-up for 2014/7/24 - Operating Results For Second Quarter And First Six Months Of 2014 Announced By Realty Income investment picks
Zeldes Haeggquist & Eck, LLP , a shareholder and consumer rights litigation firm, has commenced an investigation on behalf of investors who purchased Molycorp Inc. (NYSE: MCP) Senior Convertible 6.00% Notes due 9/1/2017 (the “Notes”). Specifically, Zeldes Haeggquist & Eck, LLP is investigating whether Molycorp and its top executives and officers made false and misleading statements in the prospectus and registration statement that the Company provided when issuing the Notes to the public on August 17, 2012.
Sign-up for - Zeldes Haeggquist & Eck, LLP Announces Investigation of Molycorp, Inc. Senior Convertible 6.00% Notes Due 9/1/2017 investment picks
HOUSTON, July 24, 2014 (GLOBE NEWSWIRE) -- Furmanite Corporation (NYSE:FRM) , a worldwide technical services and engineering and construction solutions firm, will hold a conference call to discuss its second quarter 2014 financial results on Thursday, July 31, 2014, at 10:00 a.m. Eastern Time (9:00 a.m. Central). The speakers' audio will be supported by a slide presentation on the internet.
Sign-up for - Furmanite Corporation Announces Conference Call to Discuss Quarter Ended June 30, 2014 Results investment picks
Kaplan, Inc. , the global education company and largest subsidiary of the Graham Holdings Company (NYSE: GHC), and Techstars , the global startup accelerator, announced today the 12 education-technology startups selected to participate in the Kaplan EdTech Accelerator , powered by Techstars, their three-month immersive mentorship and business development program beginning today in New York City.
Sign-up for - Kaplan EdTech Accelerator, Powered by Techstars, Announces 2014 Class of Education Technology Startups investment picks
2014/7/24
Onco360, the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services company, today announced that it has been selected to be part of the highly limited Specialty Pharmacy network of Zydelig (idelalisib) tablets.
Sign-up for 2014/7/24 - Onco360® Named to Zydelig® (Idelalisib) Limited Distribution Network; Zydelig is Available Immediately for Order Through Onco360 investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that published results from PARADOX – the most comprehensive research to date analyzing the burden of illness of Hypoparathyroidism – show a majority of patients with the disorder report experiencing a multitude of physical, emotional and cognitive symptoms that have an impact on both their personal and professional lives.
Sign-up for - PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - Altera Announces Second Quarter Results; Raises Dividend to - PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices